Octopirox Data Supports Inclusion In OTC Anti-Dandruff Rule – Clariant
This article was originally published in The Rose Sheet
Executive Summary
The safety and efficacy of dandruff control ingredient piroctone olamine in .05%-.5% and .1%-1% concentrations in leave-on and rinse-off products, respectively, is established by animal and human data, warranting the ingredient's inclusion in the OTC anti-dandruff monograph, according to Clariant
You may also be interested in...
FDA To Review Piroctone Olamine For OTC Dandruff Monograph Status
FDA is seeking safety and efficacy data on piroctone olamine for use as a single active ingredient in dandruff control products, the agency announced in a Federal Register 1notice Feb. 18
OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"
With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program
Beauty Claims Inch Closer To Pharma As Cosmeceutical Sector Expands
Though global market-size estimates differ, analysts at SupplySide West 2010 in Las Vegas agreed that cosmeceuticals remain a promising growth vehicle